• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[2016 Chinese guideline for the management of dyslipidemia in adults].

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Oct 24;44(10):833-853. doi: 10.3760/cma.j.issn.0253-3758.2016.10.005.

DOI:10.3760/cma.j.issn.0253-3758.2016.10.005
PMID:27903370
Abstract
摘要

相似文献

1
[2016 Chinese guideline for the management of dyslipidemia in adults].《2016中国成人血脂异常防治指南》
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Oct 24;44(10):833-853. doi: 10.3760/cma.j.issn.0253-3758.2016.10.005.
2
[Key points and comments on the 2016 Chinese guideline for the management of dyslipidemia in adults].[2016年中国成人血脂异常防治指南要点与点评]
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Oct 24;44(10):827-829. doi: 10.3760/cma.j.issn.0253-3758.2016.10.003.
3
[Awareness rate, treatment rate and control rate of dyslipidemia in Chinese adults, 2010].[2010年中国成年人血脂异常知晓率、治疗率及控制率]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Aug;46(8):687-91.
4
KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD.KDIGO 美国专家组关于 2013 年改善全球肾脏病预后组织（KDIGO）慢性肾脏病血脂管理临床实践指南的解读。
Am J Kidney Dis. 2015 Mar;65(3):354-66. doi: 10.1053/j.ajkd.2014.10.005. Epub 2014 Nov 18.
5
[Short-term impact of modified blood-lipid reports on physicians' lipid lowering drug prescribing behavior and knowledge improvement on dyslipidemia].[改良血脂报告对医生降脂药物处方行为及血脂异常知识改善的短期影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Apr;40(4):318-22.
6
Chinese guideline for lipid management (2023): a new guideline rich in domestic elements for controlling dyslipidemia.《中国血脂管理指南（2023年）》：一部富含国内元素的控制血脂异常的新指南。
J Geriatr Cardiol. 2023 Sep 28;20(9):618-620. doi: 10.26599/1671-5411.2023.09.007.
7
The prevalence, awareness, treatment and control of dyslipidemia among adults in China.中国成年人血脂异常的患病率、知晓率、治疗率及控制率
Atherosclerosis. 2016 May;248:2-9. doi: 10.1016/j.atherosclerosis.2016.02.006. Epub 2016 Feb 27.
8
High prevalence of dyslipidemia and associated risk factors among rural Chinese adults.中国农村成年人血脂异常及相关危险因素的高患病率。
Lipids Health Dis. 2014 Dec 12;13:189. doi: 10.1186/1476-511X-13-189.
9
Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.载脂蛋白 A-I 和 B 水平、血脂异常和代谢综合征与中国西南部多囊卵巢综合征妇女。
Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6.
10
Risk factors for dyslipidemia in Chinese children.中国儿童血脂异常的危险因素。
Acta Paediatr. 2008 Oct;97(10):1449-53. doi: 10.1111/j.1651-2227.2008.00946.x. Epub 2008 Jul 17.

引用本文的文献

1
MHR Was Associated with Hyperuricemia Risk in Patients with Type 2 Diabetes Mellitus: The Mediating Effect of Body Mass Index.2型糖尿病患者的MHR与高尿酸血症风险相关：体重指数的中介作用
Diabetes Metab Syndr Obes. 2025 Aug 22;18:3015-3025. doi: 10.2147/DMSO.S535669. eCollection 2025.
2
Comparative efficacy of eight traditional Chinese medicines combined with statins in the treatment of hyperlipidemia: a Bayesian network meta-analysis.八种中药联合他汀类药物治疗高脂血症的疗效比较：一项贝叶斯网络荟萃分析
Front Pharmacol. 2025 Aug 5;16:1614767. doi: 10.3389/fphar.2025.1614767. eCollection 2025.
3
Associations of nutrient intake, dietary behaviours, and patterns with metabolic profiles and obesity measures: findings from a cross-sectional study in a southern Chinese population.
营养摄入、饮食行为和模式与代谢特征及肥胖指标的关联：一项针对中国南方人群的横断面研究结果
Front Nutr. 2025 Aug 1;12:1586106. doi: 10.3389/fnut.2025.1586106. eCollection 2025.
4
Association of ABCB1 G2677T polymorphism with atorvastatin lipid efficacy and extended prognosis in patients with cerebral ischemic stroke.ABCB1基因G2677T多态性与阿托伐他汀对脑缺血性卒中患者血脂疗效及远期预后的相关性
Sci Rep. 2025 Aug 17;15(1):30132. doi: 10.1038/s41598-025-15434-6.
5
Serum tyrosine increases all-cause mortality in an older population.血清酪氨酸会增加老年人群的全因死亡率。
Front Endocrinol (Lausanne). 2025 Jul 23;16:1552752. doi: 10.3389/fendo.2025.1552752. eCollection 2025.
6
Identification of optimal cutoffs for obesity and lipid-related indices in screening activities of daily living disability in Chinese middle-aged and elderly adults.确定中国中老年人群日常生活能力残疾筛查中肥胖及血脂相关指标的最佳临界值。
Front Nutr. 2025 Jul 9;12:1599851. doi: 10.3389/fnut.2025.1599851. eCollection 2025.
7
Residential Greenness and the Incidence of Dyslipidemia in Chinese Adults: A Large Prospective Cohort Study.居住环境绿化与中国成年人血脂异常发生率：一项大型前瞻性队列研究
Environ Health (Wash). 2025 Apr 22;3(7):777-786. doi: 10.1021/envhealth.4c00278. eCollection 2025 Jul 18.
8
Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial.瑞舒伐他汀与依折麦布固定剂量复方制剂多剂量给药对比瑞舒伐他汀单药治疗中国高胆固醇血症患者（ROSE-CH）：多中心随机对照试验
Lipids Health Dis. 2025 Jul 22;24(1):249. doi: 10.1186/s12944-025-02670-y.
9
The Association of Circulating Bone Morphogenetic Protein 9 and Arterial Stiffness in Hypertensive Patients.高血压患者循环骨形态发生蛋白9与动脉僵硬度的关联
J Clin Hypertens (Greenwich). 2025 Jun;27(6):e70086. doi: 10.1111/jch.70086.
10
Relationship of small dense low-density lipoprotein cholesterol level with pre-diabetes and newly detected type 2 diabetes.小而密低密度脂蛋白胆固醇水平与糖尿病前期及新诊断2型糖尿病的关系。
Sci Rep. 2025 Jun 4;15(1):19500. doi: 10.1038/s41598-025-03133-1.